UnitedHealth Group is one of the largest health care companies in the United States.
UnitedHealthcare provides health insurance. Optum provides medical care, pharmacy services, data, technology, and business services.
Business Quality
UnitedHealth has two connected businesses.
UnitedHealthcare collects insurance premiums and pays members’ medical costs. Optum provides care, pharmacy benefits, technology, and services to patients, employers, insurers, and health care providers.
This structure gives UnitedHealth significant scale, data, provider relationships, and bargaining power across the health care system.
However, UNH is now a turnaround situation. Medical costs rose faster than expected. The company also faced management changes, regulatory investigations, restructuring, weaker Optum results, and declining membership in some areas.
The long-term business remains valuable, but investors need proof that margins and earnings can recover.
Latest Earnings
UnitedHealth reported Q1 2026 results on April 21, 2026.
Revenue: $111.7 billion, up 2%
Operating earnings: $9.0 billion, down 1%
Net income: $6.3 billion, roughly flat
Diluted EPS: $6.90
Adjusted EPS: $7.23
Operating cash flow: $8.9 billion
Medical care ratio: 83.9%, improved from 84.8%
UnitedHealthcare revenue: $86.3 billion, up 2%
UnitedHealthcare operating profit: $5.7 billion, up 9%
Optum revenue: $63.7 billion, roughly flat
Optum operating profit: $3.3 billion, down 15%
The quarter was better than expected.
UnitedHealthcare improved because of pricing changes, cost controls, and better development in prior medical claims. The medical care ratio also improved.
However, Optum remained weak. Earnings declined across several Optum businesses.
UnitedHealthcare served about 1.1 million fewer medical members than one year earlier. Medicare Advantage membership declined as the company reduced exposure to plans that were not producing acceptable returns.
Management raised its 2026 adjusted EPS outlook to more than $18.25.
Profitability & Balance Sheet
ROE: Approximately 12%
ROIC: Approximately 9%
Debt to EBITDA: Approximately 3.38x
UnitedHealth’s profitability has weakened.
ROE of 12% and ROIC of 9% are below the levels we normally prefer for a high-quality long-term compounder. The company is still profitable, but returns on capital have declined as earnings weakened and acquisitions increased the amount of capital invested in the business.
Debt to EBITDA of 3.38x is also higher than I prefer. The company still produces strong cash flow, but the balance sheet is no longer as comfortable as it was in the past.
UnitedHealth must improve earnings, strengthen Optum, and reduce leverage to rebuild its financial quality.
Moat Score
Brand Loyalty: 7
Barriers to Entry: 9
Switching Costs: 8
Network Effect: 8
Cost Advantage: 8
Final Moat Score: 8.0 / 10
Moat Rating: Wide Moat
UnitedHealth’s moat comes from its scale, insurance network, provider relationships, pharmacy operations, health care data, and regulatory experience.
However, regulation, public pressure, and government reimbursement rules can limit how much the company benefits from its scale.
Main Risks
The main risks are rising medical costs, incorrect insurance pricing, Medicare Advantage funding changes, government investigations, legal action, weaker Optum margins, cybersecurity problems, high debt, and damage to public trust.
The company must also prove that it can improve profitability without creating more pressure on patients, providers, or regulators.
For our fair value estimate, buy zones, and full investment view, join our private investing group. Members receive the complete analysis, including how we evaluate the company’s risks, current opportunity, and the price levels we consider most attractive.
